Research on Clinical Data Processing and Quality Assurance with the National Center of Neurology and Psychiatry
First written in FY2022. 2 of 4 entries say "Restated". Latest entry: FY2023.
1 other company's latest entry also says "Restated".
- FY2023RestatedAnnual report
「The initiative with the National Center of Neurology and Psychiatry concerning the development and social implementation of a mental health platform using the all-generation remote mental healthcare system (KOKOROBO-J) has been selected for JST's FY2022 COI-NEXT program, the Program on Open Innovation Platforms for Co-creation.」
The company describes the selection by JST of an initiative with the National Center of Neurology and Psychiatry and its aim of achieving social implementation. - FY2023-Q3RestatedAnnual report
「In joint research with academia and other institutions, new initiatives with Nagoya City University, Yokohama City University, the National Center of Neurology and Psychiatry, and others were selected for programs operated by the Japan Agency for Medical Research and Development (AMED) and the Japan Science and Technology Agency (JST).」
The selection by AMED and JST of initiatives including research with the National Center of Neurology and Psychiatry on clinical data processing and quality assurance continues to be disclosed. - FY2023-Q2AdvancedAnnual report
「New initiatives with Nagoya City University, a public university corporation, Yokohama City University, a public university corporation, the National Center of Neurology and Psychiatry, an incorporated national research and development agency, and others have been selected for programs operated by the Japan Agency for Medical Research and Development and the Japan Science and Technology Agency.」
The selection by AMED and JST of initiatives involving the National Center of Neurology and Psychiatry was disclosed. - FY2022First statedAnnual report
「Research and development has begun with the National Center of Neurology and Psychiatry, an incorporated national research and development agency, on methods for processing clinical data and ensuring data quality to promote the use of data.」
The commencement of research and development on processing methods and data quality assurance for the use of clinical data was disclosed for the first time.